The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples
Read MoreAccurate Diagnostic Laboratories and RUCDR Infinite Biologics through its Clinical Genomics Laboratory are pleased to announce they have implemented a test that will allow virtually anyone to test for COVID-19.
Read More